Pancreatic Cancer: New Treatment Doubles Survival - Access Also for Patients in Greece
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.6 Articles
6 Articles
Daraxonrasib is the first drug in many years that appears to have significant effects on pancreatic cancer.
Modern medicine is making leaps and bounds as the latest discoveries in the treatment of pancreatic cancer give hope to thousands of people who suffer from it. The ... The article Pancreatic Cancer: Innovative Drug Doubles Patients' Life Expectancy was published in NewsIT.
Pancreatic cancer remains one of the most difficult cancers to treat, with approximately 500,000 new diagnoses worldwide each year and low five-year survival rates. The frequent diagnosis at an advanced stage and the limited treatment options, especially for patients with metastatic disease, make the development of new therapies imperative. New perspective in therapeutic […]
rthess.gr
Pancreatic cancer remains one of the most difficult cancers to treat, with approximately 500,000 new diagnoses worldwide each year and low five-year survival rates. The frequent diagnosis at an advanced stage and limited treatment options, particularly for
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
